2019 American Transplant Congress
TDCA/Valine Reverse Obesity and Ameliorate Alloimmune Responses through a Decreased Hypothalamic Expression of MCH
1Brigham and Women's Hospital, Boston, AL, 2Beth Israel Deaconess Medical Center, Boston, AL
*Purpose: Obesity is associated with low grade inflammation and bariatric surgery is the only effective treatment in reducing excess weight both pre- and post-transplant.*Methods: Here,…2019 American Transplant Congress
Association Of Lymphocyte-depleting Antibody And Steroids Induction With The Risk And Outcomes Of Post-transplant Diabetes: Analysis Of Deceased-donor Kidney Transplants
*Purpose: We aimed to determine the risk and outcomes of post-transplant diabetes(PTDM) associated with combined lymphocyte-depleting antibody (LDA) [anti-thymocyte globulin (ATG) or alemtuzumab (ALM)] and…2019 American Transplant Congress
Impact of Hepatitis C Viremia on Post-Transplant Diabetes Mellitus Development in Liver Transplant Recipients
*Purpose: Compare incidence of post-transplant diabetes mellitus (PTDM) in hepatitis C virus (HCV) patients with and without viremia at the time of orthotopic liver transplantation…2019 American Transplant Congress
Pharmacist-Led Management of Post-Transplant Hyperglycemia Reduces Hospitalizations
*Purpose: Renal transplant recipients (RTRs) are at risk of developing post-transplant hyperglycemia (PTHG), defined as blood glucose > 180 mg/dL within the first 45 days…2019 American Transplant Congress
Serum Apolipoproteins B and A1 Predict the Development of Late Post-Transplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients
St Michael's Hospital, University of Toronto, Toronto, ON, Canada
*Purpose: Post-transplant diabetes mellitus (PTDM) increases adverse outcomes. The risk factors for PTDM have not been fully delineated. Glucose metabolism links closely to cholesterol metabolism.…2018 American Transplant Congress
Prevention of New Onset Diabetes after Transplantation Using Bariatric Surgery
Transplant Surgery, University of Cincinnati, Cincinnati, OH.
New onset diabetes after transplantation (NODAT) is a common complication, occurring 20-36% after renal transplant historically and 15.8% at our institution. Obesity is a known…2018 American Transplant Congress
The Implications of Impaired Glucose Tolerance after Kidney Transplantation
Background: Post-transplantation diabetes mellitus (PTDM) is highly prevalent after kidney transplantation and associated with significant morbidity. Routine utilization of screening oral glucose tolerance tests (OGTT)…2018 American Transplant Congress
Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes
INTRODUCTION: mTOR inhibitors alter lipids and carbohydrate metabolism in kidney transplant recipients. Little is known if there is any difference between patients who were already…2018 American Transplant Congress
Prevalence of Abnormal Hemoglobin A1C in Pediatric Kidney Transplant Recipients
Background: The incidence of new-onset diabetes after kidney transplantation (NODAT) in the pediatric population has not been well characterized. Early recognition of glucose intolerance may…2018 American Transplant Congress
Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol
University of Illinois, Chicago.
Purpose: In 2005, an internal retrospective review of kidney transplant recipients (KTx) showed a higher incidence of post transplant diabetes mellitus (PTDM) for Hispanic patients…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- Next Page »